CRISPRjournal's profile picture. Cutting-edge peer-reviewed research and analysis on genome editing for the global CRISPR community. 
EIC @crisprchef | Exec Ed @kevinadavies 
@liebertpub

The CRISPR Journal

@CRISPRjournal

Cutting-edge peer-reviewed research and analysis on genome editing for the global CRISPR community. EIC @crisprchef | Exec Ed @kevinadavies @liebertpub

The CRISPR Journal أعاد

Huntington's disease has been successfully treated for the first time, doctors tell BBC bbc.in/46jnMiX


Join our colleagues @GENbio for "The State of Biotech" 4-hr virtual event, today at 11 am ET/8 am PT. Highlights include a keynote interview with George Church with our Exec Editor, @KevinADavies. Registration is free:


The CRISPR Journal أعاد

Deeply saddened by the loss of David Baltimore - a mentor, role model, and scientific giant who shaped so many of us. Most memorably, I was sitting next to David, a month after I started as a baby Assistant Professor, when I learned about CRISPR. His kindness and wisdom will be…


The CRISPR Journal أعاد

LAST CHANCE! TODAY, Vicky Smith, PhD, an expert in RNA biology, will provide a practical blueprint for enhancing mRNA quality using proven manufacturing strategies from TriLink’s 25+ years of expertise. REGISTER: hubs.li/Q03CRKkz0 @TriLinkBioTech

LiebertPub's tweet image. LAST CHANCE! TODAY, Vicky Smith, PhD, an expert in RNA biology, will provide a practical blueprint for enhancing mRNA quality using proven manufacturing strategies from TriLink’s 25+ years of expertise. REGISTER: hubs.li/Q03CRKkz0 @TriLinkBioTech

The CRISPR Journal أعاد

For those who read our group's lncRNA study published last year, we have recently learned that the Cas13 library included some gRNAs that were not properly filtered for potential off-targets (as described in the Methods). While this does not affect the study's main conclusions,…

🚨🚨🚨 Thrilled to share our newest study — identifying functional long noncoding RNAs using transcriptome-scale RNA-targeting CRISPR screens. 🔎🔎🔎 We hope this scalable approach will be helpful for folks who want to connect noncoding RNAs to phenotypes & diseases.



The CRISPR Journal أعاد

Can You Afford a Cure? The Gene Editing Dilemma - interview with Alta Charo youtu.be/ZqRR6-fQio8?si… via @YouTube

KevinADavies's tweet card. Can You Afford a Cure? The Gene Editing Dilemma

youtube.com

YouTube

Can You Afford a Cure? The Gene Editing Dilemma


The 2025 @ArrigeOrg annual meeting is being held Oct 28-29 in Strasbourg (hybrid). Speakers include: Fabiana Arzuaga, Argentina Marina Cavazzana, France Kazuto Kato, Japan Kiran Musunuru, USA Michael Pepper, SA Pawel Luckow, Poland Julian März, Switzerland arrige.org/portfolio/2025…

CRISPRjournal's tweet image. The 2025 @ArrigeOrg annual meeting is being held Oct 28-29 in Strasbourg (hybrid).
Speakers include:
Fabiana Arzuaga, Argentina
Marina Cavazzana, France
Kazuto Kato, Japan
Kiran Musunuru, USA
Michael Pepper, SA
Pawel Luckow, Poland
Julian März, Switzerland
arrige.org/portfolio/2025…

The CRISPR Journal أعاد

When it comes to deep learning for protein engineering, there is strength in simplicity. In a Preview piece @CellCellPress, we highlight work from @CaixiaGaoLab on using fixed-backbone sequence design to engineer genome editors with improved function. 📄 authors.elsevier.com/a/1leKGL7PXuFlF

avapamini's tweet image. When it comes to deep learning for protein engineering, there is strength in simplicity.

In a Preview piece @CellCellPress, we highlight work from @CaixiaGaoLab on using fixed-backbone sequence design to engineer genome editors with improved function.

📄 authors.elsevier.com/a/1leKGL7PXuFlF

The CRISPR Journal أعاد

Terrana Biosciences is looking to hire two Contract Research Associates to join our Delivery and Transformation team in Durham, NC. job-boards.greenhouse.io/terranabio/job…


The CRISPR Journal أعاد

Here’s a great interview of @davidrliu - the Co-founder of $BEAM & $PRME, in @GrinsteinJ “Behind the Breakthroughs” podcast in which they talk about CRISPR & Gene Editing & about the way that Prof. Liu’s groundbreaking modalities - Base & Prime Editing, are already saving lives!

When I first joined @GENbio in 2022, there was one name I kept hearing seemingly weekly: @davidrliu. David Liu's lab invented base and prime editing (gene editing tools now in 20+ clinical trials with early wins against sickle cell, leukemia, and more). In this episode of…

GrinsteinJ's tweet image. When I first joined @GENbio in 2022, there was one name I kept hearing seemingly weekly: @davidrliu. David Liu's lab invented base and prime editing (gene editing tools now in 20+ clinical trials with early wins against sickle cell, leukemia, and more).

In this episode of…


Our August issue is online now: A special issue on the proceedings of the 2025 Global Observatory for Genome Editing conference, including a post-conference statement from the organizers. liebertpub.com/toc/crispr/8/4 (Full access for a limited time.)

CRISPRjournal's tweet image. Our August issue is online now:
A special issue on the proceedings of the 2025 Global Observatory for Genome Editing conference, including a post-conference statement from the organizers.
liebertpub.com/toc/crispr/8/4
(Full access for a limited time.)

The CRISPR Journal أعاد

When I first joined @GENbio in 2022, there was one name I kept hearing seemingly weekly: @davidrliu. David Liu's lab invented base and prime editing (gene editing tools now in 20+ clinical trials with early wins against sickle cell, leukemia, and more). In this episode of…

GrinsteinJ's tweet image. When I first joined @GENbio in 2022, there was one name I kept hearing seemingly weekly: @davidrliu. David Liu's lab invented base and prime editing (gene editing tools now in 20+ clinical trials with early wins against sickle cell, leukemia, and more).

In this episode of…

The CRISPR Journal أعاد

🚀 The State of Biotech 2025 — hosted by @GENbio. Wed, Sept 24 | 11 AM–3:30 PM ET. Free virtual summit with leaders in AI, CRISPR & biotech innovation. 🔗 hubs.li/Q03CbDfF0 #Biotech #LifeSciences #Innovation #StateOfBiotech

LiebertPub's tweet image. 🚀 The State of Biotech 2025 — hosted by @GENbio.
Wed, Sept 24 | 11 AM–3:30 PM ET.

Free virtual summit with leaders in AI, CRISPR & biotech innovation.
🔗 hubs.li/Q03CbDfF0

#Biotech #LifeSciences #Innovation #StateOfBiotech

"A “Bare Hope of A Result”: The Second CRISPR Patent Appeal" -- Jacob Sherkow @jsherkow liebertpub.com/doi/10.1177/25…

CRISPRjournal's tweet image. "A “Bare Hope of A Result”: The Second CRISPR Patent Appeal"
-- Jacob Sherkow @jsherkow 
liebertpub.com/doi/10.1177/25…

"Bacterial Expression System with Deep Repression and Activation via CRISPR-Cas9" liebertpub.com/doi/10.1177/25… Manuvera et al.

CRISPRjournal's tweet image. "Bacterial Expression System with Deep Repression and Activation via CRISPR-Cas9"
liebertpub.com/doi/10.1177/25…
Manuvera et al.

New online: "Implementation of an Undergraduate Laboratory-Based Mammalian Genome Editing Course" liebertpub.com/doi/10.1089/cr… Guerra et al.

CRISPRjournal's tweet image. New online:
"Implementation of an Undergraduate Laboratory-Based Mammalian Genome Editing Course"
liebertpub.com/doi/10.1089/cr…
Guerra et al.

Malaria Transmission Blocked by One-Amino-Acid Mosquito CRISPR Edit in FREP1 - new work from Ethan Bier's group in Nature genengnews.com/topics/infecti… via @GENbio


The CRISPR Journal أعاد

🚀 Join CongLab @Stanford! We’re hiring postdocs to create lab-in-the-loop self-evolving AI agents, open benchmarks, to design, test & learn—advancing safer gene & cell therapies. Build on CRISPR-GPT, RNAGenesis model, Genome-Bench, for innovative medicines. #PostdocJobs


The CRISPR Journal أعاد

A new #CRISPR Cures center, funded by $20M from @czi and led by @UrnovFyodor, will create 8 custom therapies for patients in the next 3 years. “Our goal is to aggressively walk the walk of CRISPR platformization,” Urnov told me. More in @endpts: endpoints.news/crispr-cures-c…


Loading...

Something went wrong.


Something went wrong.